Understanding adjuvant chemotherapy for breast cancer.
Goldhirsch
A
A
Gelber
R D
RD
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D004273:DNA, Neoplasm / Q000032:analysis; D004317:Doxorubicin / Q000008:administration & dosage; D066246:ErbB Receptors / Q000032:analysis; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D011518:Proto-Oncogene Proteins / Q000032:analysis; D018719:Erb-b2 Receptor Tyrosine Kinases
D003520:Cyclophosphamide; D004273:DNA, Neoplasm; D004317:Doxorubicin; D066246:ErbB Receptors; D005472:Fluorouracil; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases